Myhre syndrome is caused by dominant-negative dysregulation of SMAD4 and other co-factors

This publication has 54 references indexed in Scilit:

• A Restricted Spectrum of Mutations in the SMAD4 Tumor-Suppressor Gene Underlies Myhre Syndrome
  The American Journal of Human Genetics, 2012
• Smad1 plays an essential role in bone development and postnatal bone formation
  Osteoarthritis and Cartilage, 2011
• Novel dominant negative Smad antagonists to TGFβ signaling
  Cellular Signalling, 2007
• Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
  Genes & Development, 2006
• Smad4 haploinsufficiency in mouse models for intestinal cancer
  Oncogene, 2006
• Role of Smad4 on TGF-β–induced extracellular matrix stimulation in mesangial cells
  Kidney International, 2003
• Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways
  Journal of Clinical Investigation, 1999
• A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF‐β signals
  FEBS Letters, 1998
• Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators
  Molecular Cell, 1998
• Dominant-Negative SMAD-3 Interferes with Transcriptional Activation by Multiple Agonists
  Biochemical and Biophysical Research Communications, 1997